One Wealth Advisors’s Gilead Sciences GILD Stock Holding History

One Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Sell	8,621 -954	-10%	-$126K	0.12%	95
2026 Q1	$1.33M	Sell	9,575 -1,622	-14%	-$227K	0.17%	81
2025 Q4	$1.37M	Buy	11,197 +2,249	+25%	+$273K	0.17%	80
2025 Q3	$993K	Sell	8,948 -215	-2%	-$24.4K	0.12%	94
2025 Q2	$1.02M	Buy	9,163 +2,364	+35%	+$252K	0.14%	89
2025 Q1	$762K	Buy	+6,799	New	+$702K	0.11%	110
2024 Q1	–	Sell	-2,977	Closed	-$241K	–	251
2023 Q4	$241K	Sell	2,977 -514	-15%	-$40K	0.05%	186
2023 Q3	$262K	Buy	+3,491	New	+$269K	0.06%	152
2019 Q2	–	Sell	-63	Closed	-$4K	–	252
2019 Q1	$4K	Buy	+63	New	+$4.19K	﹤0.01%	389
2018 Q4	–	Sell	-5,233	Closed	-$404K	–	243
2018 Q3	$404K	Sell	5,233 -3,870	-43%	-$292K	0.31%	51
2018 Q2	$645K	Buy	9,103 +460	+5%	+$32.5K	0.52%	24
2018 Q1	$652K	Buy	8,643 +1,471	+21%	+$117K	0.58%	17
2017 Q4	$514K	Buy	+7,172	New	+$545K	0.42%	31

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

One Wealth Advisors's GILD Position: Q2 2026 in Review

One Wealth Advisors reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $126K and leaving 8,621 shares worth $1.09M. The position accounts for 0.12% of the portfolio, ranked #95.

One Wealth Advisors first reported a position in GILD in Q4 2017 and has held it in 13 quarters since. The position peaked at $1.37M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

One Wealth Advisors held 8,621 shares of Gilead Sciences worth $1.09M as of Q2 2026.
One Wealth Advisors sold 954 Gilead Sciences shares in Q2 2026, an estimated $126K.
Gilead Sciences made up 0.12% of One Wealth Advisors's portfolio in Q2 2026, its #95 holding.
One Wealth Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 13 quarters since.
One Wealth Advisors's Gilead Sciences position peaked at $1.37M in Q4 2025.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.